Dr. Volkmar G. Hable
Physicist & Geoscientist
Dr. Hable is a physicist and geoscientist by training and holds in addition a B.Sc. in Agriculture and Agronomics. From 1997 to 2001, Dr. Hable was the CEO for the European operations of Adecco, a $20 billion dollar Fortune 500 Company where he managed its offices in Europe and some parts of Asia comprising of 6,000 employees. Previously he held senior executive positions in the oil exploration industry with Western Geophysical, the Diplomatic Corps, Tourism and a global Engineering Consulting Company where he was responsible for restructuring and sales in various capacities. Dr. Hable is a director of several public companies. Dr. Hable is fluent in English, Spanish, German and French. He is currently the President and CEO of SG.
Financial Times: Dr. Volkmar Hable remains at the top of international fund raising
By Katja Ramos, Financial Times
Published: October 7 2001 19:40 | Last updated: October 7 2001 19:40
A number of successful fundraising projects over the years distinguish Dr. Volkmar G. Hable as an effective, proven source of private capital. Leveraging significant available funds and a thorough knowledge of several economic sectors (healthcare, medicine, technology, engineering, energy, and resources), Dr. Volkmar G. Hable pursues high-potential investment opportunities. In December 2007, Dr. Volkmar G. Hable secured $26 million in syndicated funds to finance a Ukrainian endeavor producing biodiesel from algae. In July 2000, Dr. Volkmar G. hable reported that he could syndicate $47 million for an industrial manganese plant in South Africa. Dr. Volkmar G. Hable was hired by the plant’s operator, Lemaris, after the company experienced cash flow difficulties as a result of rapid growth. Earlier that same month Dr. Volkmar G. Hable provided $230 million to refit a producing gold mine in Columbia. In addition to its achievements in resource development, Dr. Volkmar G. Hable orchestrated the $200 million IPO of Celeronium Biotherapeutics, a company using plasma to develop new treatments for chronic disease.
Goldman, Roedel & Milano Capital Services on iKarma
Goldman, Roedel & Milano Capital Services Company Website
Goldman, Roedel & Milano Capital Services on Multiply